Next Article in Journal
The Role of Peanuts and Tree Nuts in Improving Diet and Sleep Quality: A Pilot Study and Literature Review
Previous Article in Journal
The Role of Vitamin D3 in Periodontal Health: Implications for Bone Metabolism, Immune Modulation and Inflammation Control
Previous Article in Special Issue
Inflammatory Bowel Disease, Gastrointestinal Graft-Versus-Host Disease and Immune Checkpoint Inhibitors Induced Colitis: Similar Diseases to Treat with Fecal Microbiota Transplantation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Diet–Microbiota–Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications

by
Alice N. Mafe
1 and
Dietrich Büsselberg
2,*
1
Department of Biological Sciences, Faculty of Sciences, Taraba State University, Main Campus, Jalingo 660101, Taraba State, Nigeria
2
Department of Physiology and Biophysics, Faculty of Medicine, Qatar Campus, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha Metropolitan Area, Doha P.O. Box 22104, Qatar
*
Author to whom correspondence should be addressed.
Nutrients 2026, 18(4), 578; https://doi.org/10.3390/nu18040578
Submission received: 12 January 2026 / Revised: 7 February 2026 / Accepted: 8 February 2026 / Published: 10 February 2026
(This article belongs to the Special Issue Diet–Microbiome Interaction in Gastrointestinal Disorders)

Abstract

Intestinal aging is characterized by a gradual decline in epithelial renewal capacity, barrier function, immune balance, and metabolic regulation, often accompanied by shifts in gut microbial composition. Polyamines, including putrescine, spermidine, and spermine, are vital microbial–host metabolites that support intestinal cell growth, autophagy, immune modulation, and mucosal repair. With advancing age, both host-derived and microbiota-mediated polyamine production declines, contributing to intestinal dysfunction and heightened vulnerability to inflammation and age-related disorders. This review explores the diet–microbiota–polyamine axis as a key biological framework influencing intestinal aging. It aims to integrate evidence on how dietary components and functional foods shape gut microbial ecology and, in turn, regulate microbial polyamine biosynthetic pathways that impact intestinal health. The review highlights major microbial contributors to polyamine metabolism, particularly lactic acid bacteria, and outlines mechanistic pathways linking polyamines to epithelial regeneration, inflammatory control, and gut barrier maintenance. It further discusses how age-associated dysbiosis disrupts these interactions and evaluates nutritional and microbial-based strategies such as fermented foods, prebiotics, and probiotics that may enhance polyamine availability and restore gut homeostasis. From the standpoint of food microbiology and human physiology, this synthesis underscores the translational potential of targeting microbial polyamine production through diet-based interventions. This article presents a narrative review synthesizing experimental, animal, and emerging human evidence on microbial and dietary polyamines in intestinal aging. In conclusion, modulating the diet–microbiota–polyamine axis represents a promising strategy to promote healthy intestinal aging, meriting deeper mechanistic exploration and validation through clinical studies.

1. Introduction

Polyamines are low-molecular-weight, positively charged compounds that are universally distributed in living organisms, with putrescine, spermidine, and spermine representing the principal forms in human biology [1,2]. These molecules are indispensable for cellular homeostasis, as they regulate nucleic acid stability, protein translation, cell growth, autophagy, and adaptive stress responses [3,4]. Within the gastrointestinal tract, polyamines are essential due to the high turnover rate of intestinal epithelial cells, where they support mucosal integrity, epithelial renewal, and tissue repair [5,6]. Intestinal polyamine pools arise from a combination of host biosynthesis, dietary sources, and microbial metabolism [7]. In the context of this review, “intestinal health” refers to the maintenance of epithelial renewal capacity, intact barrier function, balanced mucin secretion by goblet cells, regulated enteroendocrine signaling, and controlled mucosal immune responses. These processes are particularly vulnerable during aging and are central targets of polyamine-mediated regulation. A critical consideration throughout this review is that the mechanistic and physiological roles attributed to polyamines are supported by varying levels of evidence, predominantly derived from in vitro and animal studies, with human observational data and clinical intervention studies remaining comparatively limited and explicitly distinguished where applicable.
A gradual yet significant functional decline accompanies intestinal aging. Hallmark features include weakened epithelial barrier function, increased intestinal permeability, chronic low-grade inflammation, and dysregulated immune responses [8,9]. These physiological alterations are frequently paralleled by age-related gut dysbiosis, marked by reduced microbial diversity and a decline in beneficial taxa alongside an expansion of inflammation-associated microbes [10,11]. Collectively, these changes undermine gut homeostasis and contribute to systemic inflammation and the progression of age-associated diseases.
The gut microbiota is a key determinant of polyamine availability, functioning as both a producer and modulator of these metabolites [12,13]. Numerous intestinal microbes, including lactic acid bacteria and other commensals, harbor enzymatic pathways that convert dietary amino acids into bioactive polyamines [14,15]. Once produced, microbially derived polyamines can influence host signaling pathways involved in epithelial proliferation, immune regulation, and inflammatory control, establishing a direct mechanistic link between microbial metabolism and intestinal aging [16].
From the perspectives of food microbiology and human physiology, the microbiota–polyamine axis is particularly relevant because it is highly responsive to dietary modulation [17,18]. Functional foods, fermented products, probiotics, and prebiotic substrates can shape microbial community structure and enhance polyamine biosynthesis, offering accessible and low-risk strategies to maintain intestinal function across the lifespan [19,20].
This review aims to provide a comprehensive synthesis of current evidence on the diet–microbiota–polyamine axis in intestinal aging. It focuses on microbial polyamine biosynthetic pathways, diet-driven modulation of gut microbiota, and the physiological implications for intestinal health, while outlining future directions for food-based and microbial therapeutic interventions.

2. Polyamines: Biosynthesis, Regulation, and Functions

2.1. Biochemical Properties of Polyamines

Polyamines are low-molecular-weight, linear aliphatic compounds containing multiple amino groups, which render them polycationic under physiological conditions [21,22]. The principal polyamines in mammalian systems include putrescine, spermidine, and spermine, which vary in chain length and charge density, properties that determine their biological activity and molecular interactions [23,24]. Owing to their positive charge, polyamines readily bind to negatively charged macromolecules, including DNA, RNA, membrane phospholipids, and acidic proteins [25,26]. These interactions allow polyamines to influence chromatin architecture, stabilize nucleic acid structures, regulate ribosomal activity, and modulate membrane dynamics, positioning them as key regulators of cellular structure and signaling [27]. Owing to their polycationic nature, polyamines interact reversibly with negatively charged macromolecules such as DNA, RNA, and proteins through electrostatic forces, enabling rapid and flexible modulation of molecular organization in response to cellular metabolic conditions [28].

2.2. Microbial Versus Host Biosynthesis Pathways

Intestinal polyamine levels are controlled by a tightly regulated balance between endogenous synthesis, dietary contribution, and microbial metabolism [29]. In host tissues, polyamine biosynthesis is primarily driven by the ornithine decarboxylase (ODC) pathway, in which ornithine is decarboxylated to form putrescine, followed by sequential conversion to spermidine and spermine through aminopropyl transfer reactions [30]. Arginine also serves as an important upstream substrate, feeding into polyamine synthesis through arginine decarboxylase-dependent routes that intersect with nitrogen and amino acid metabolism [31,32]. Beyond canonical polyamines, host-derived agmatine is produced via arginine decarboxylation by arginine decarboxylase, a distinct mammalian enzyme expressed in the brain and peripheral tissues, establishing agmatine as a biologically active polyamine precursor [33]. The gut microbiota represents an additional and highly influential source of polyamines. Many intestinal bacteria harbor decarboxylase systems that convert arginine or ornithine to putrescine, with some species further synthesizing spermidine or spermine [34,35]. Microbial amino acid decarboxylation pathways include lysine decarboxylase-mediated conversion of lysine to cadaverine, which contributes to the luminal pool of biogenic amines that act as metabolite-derived signaling molecules influencing intestinal health, as demonstrated in in vitro and animal models [36]. Notably, lactic acid bacteria, Bacteroides sp., Enterococcus sp., Escherichia sp., Clostridium sp., and related taxa have been identified as contributors to luminal polyamine pools [37,38]. Figure 1 illustrates the key pathways involved in microbial- and host-derived polyamine biosynthesis, highlighting the metabolic interactions that regulate intracellular and luminal polyamine pools. Key microbial contributors to intestinal polyamine biosynthesis are outlined in Table 1. Host polyamine biosynthesis is tightly controlled by antizyme-dependent regulation of ornithine decarboxylase, with antizyme inhibitor 1 fine-tuning intracellular polyamine levels in a tissue- and stress-responsive manner [39].

2.3. Physiological Polyamines Versus Pathological Biogenic Amines

Physiological polyamines such as putrescine, spermidine, spermine, and agmatine are endogenously regulated metabolites essential for cellular growth and intestinal homeostasis, whereas biogenic amines including cadaverine, histamine, and tyramine mainly arise from bacterial amino acid decarboxylation in foods or dysbiotic environments, where excessive accumulation reflects impaired metabolic control and poses potential health risks [51]. The formation of biogenic amines in foods and beverages is largely driven by proteins and free amino acids, which serve as substrates for microbial or natural enzymes with decarboxylation or amination activity. Fermentation in products such as wine, beer, cider, and certain teas, as well as naturally occurring amines in some fruit-based drinks, significantly contributes to their levels, like underscoring the need for preventive strategies such as selecting low-decarboxylating starter cultures and good manufacturing practices [52]. Fermentation in alcoholic beverages, coffee, tea, and some fruit-based drinks can elevate biogenic amine levels, reflecting the activity of diverse microbial communities whose composition and metabolism influence both the safety and nutritional impact of these products [53]. Dietary exposure to biogenic amines should account for all potential sources, including foods and beverages, particularly for individuals with reduced metabolic capacity or those taking medications that may inhibit enzyme activity or interact with these compounds, increasing the risk of adverse effects [54,55]. The most effective strategy to limit biogenic amine accumulation is preventive, including the use of lactic acid bacteria strains with low decarboxylase activity and good manufacturing practices that control fermentation conditions, leveraging LAB’s natural antimicrobial and biopreservative properties [56]. From a biochemical and translational perspective, physiological polyamines and biogenic amines differ not only in their precursor amino acids, decarboxylase specificity, and regulatory control, but also in their metabolic context, bioavailability, intracellular handling, and functional targeting, reflecting distinct physiological roles and implications for disease [57]. Amino acid-derived polyamines are tightly regulated through feedback inhibition and enzyme specificity to maintain cellular homeostasis, whereas dysregulated or excessive amine production due to loss of metabolic control, can lead to local toxicity or off-target effects, as observed in microbial systems where feedback and enzyme abundance interact to ensure robust yet balanced biosynthesis [58]. This principle mirrors strategies in drug development, where amino acids are used as moieties in prodrugs to enhance bioavailability, decrease systemic toxicity, and achieve tissue-specific delivery, highlighting the importance of controlled precursor utilization. Moreover, the dynamic role of amino acids in rapid biological processes, such as neurotransmission, underscores that subtle differences in substrate availability, enzymatic control, and temporal release can have profound functional consequences [59,60,61]. Collectively, these considerations emphasize that the distinction between physiological polyamines and potentially harmful biogenic amines extends beyond molecular charge to include regulation, metabolic integration, and functional specificity.

3. Intestinal Aging: Biology, Pathophysiology, and Microbiota Changes

3.1. Features of the Aging Intestine

Aging is associated with notable structural and functional changes in the gastrointestinal tract. A key characteristic of the aging intestine is a decline in epithelial renewal, mainly due to reduced intestinal stem cell activity and slower crypt cell proliferation. This limits the epithelium’s capacity to replace damaged cells and maintain tissue homeostasis [62,63]. Concurrently, aging is associated with enhanced intestinal permeability, often described as a “leaky gut,” resulting from altered expression and organization of tight junction proteins. Increased permeability facilitates the passage of microbial components and dietary antigens into the underlying tissue [64,65]. In addition, the mucus barrier becomes thinner and less effective with age, reducing its protective role against microbial contact with the epithelium. These cumulative changes contribute to the development of persistent low-grade inflammation, or inflammaging, characterized by sustained immune activation and elevated pro-inflammatory mediators that further impair intestinal function and resilience [66,67]. Figure 2 compares the “young” and “aged” intestinal environments, emphasizing age-dependent differences in polyamine availability, absorption sites, and biological activity along the gut epithelium.

3.2. Age-Related Changes in the Gut Microbiota

The gut microbiota undergoes marked compositional and functional shifts during aging. One of the most consistent patterns is the beneficial microbial taxa, including species that produce protective metabolites. This loss is often accompanied by an increased prevalence of pathobionts and opportunistic bacteria that can promote inflammatory responses and epithelial stress. Together, these reduce microbial diversity and diminish metabolic flexibility in the gut ecosystem [68,69]. Beyond compositional changes, aging also affects microbial metabolic capacity. Age-associated dysbiosis is associated with reduced production of microbially derived polyamines, reflecting both the loss of key producer species and disrupted microbial cross-feeding networks. As a result, the metabolic dialogue between the microbiota and host becomes less efficient, negatively influencing intestinal health [70].

3.3. Declining Polyamine Availability During Aging

Aging is accompanied by a gradual reduction in polyamine levels within the intestine and systemically. This decline is partly due to decreased endogenous synthesis, stemming from reduced activity of polyamine biosynthetic enzymes and age-related metabolic constraints. In parallel, intestinal uptake of polyamines may be impaired as epithelial transport mechanisms and absorptive capacity deteriorate with age [71,72]. Dietary habits also play a critical role in shaping polyamine availability in older populations. Reduced intake of polyamine-rich foods and fermented products, together with changes in appetite and food diversity, can further limit exogenous polyamine supply. When combined with microbial dysbiosis and impaired host synthesis, these factors create a state of relative polyamine deficiency, which may accelerate intestinal aging and exacerbate inflammation and barrier dysfunction [73,74].

4. Microbial Polyamines in the Aging Gut

4.1. Probiotic and Commensal Sources

The gut microbiota constitutes a major reservoir of bioavailable polyamines, a role that becomes increasingly important with aging as endogenous polyamine synthesis declines. Several probiotic and commensal microorganisms contribute directly or indirectly to intestinal polyamine pools [75,76]. Lactic acid bacteria (LAB) [77], widely distributed in fermented foods and commonly employed as probiotics [78,79,80], are among the most prominent producers. These organisms can synthesize putrescine and spermidine either through intrinsic metabolic pathways or via cooperative interactions with other gut microbes [81]. Bifidobacteria, which are often less abundant in older adults, also play a key role in maintaining polyamine homeostasis. Through amino acid metabolism and cross-feeding interactions, these bacteria support the production of spermidine and spermine [82,83]. Additionally, genera such as Enterococcus sp., Bacillus sp., and Streptococcus sp. possess polyamine biosynthetic capabilities, highlighting the collective contribution of commensal microbial networks to sustaining intestinal polyamine availability during aging [84].

4.2. Mechanistic Actions of Microbial-Derived Polyamines in Intestinal Aging

Microbial-derived polyamines promote intestinal homeostasis and resilience during aging by coordinating epithelial renewal, barrier integrity, immune balance, and stress-response pathways, with preclinical evidence indicating their ability to counteract age-related microbial and inflammatory imbalances [85]. A key role of microbial polyamines is to enhance epithelial proliferation and regeneration in the aging intestine. By promoting cell cycle progression, migration, and differentiation, polyamines support mucosal repair and sustain epithelial turnover processes that decline with age. Preclinical in vitro and in vivo studies show that polyamine supplementation can restore regenerative capacity in aged epithelia [86]. Microbial polyamines support intestinal barrier integrity by regulating the expression, localization, and assembly of tight and adherens junction proteins, including E-cadherin, and by modulating cytoskeletal organization. These actions reinforce paracellular sealing, limit age-related increases in intestinal permeability, and are largely demonstrated in preclinical and in vitro models [87,88].
Beyond structural support, microbial-derived polyamines help maintain intestinal immune homeostasis by modulating innate and adaptive immune cell activity, regulating cytokine production, and influencing redox-sensitive signaling pathways. These metabolites restrain excessive inflammation and preserve mucosal balance, with evidence primarily from in vitro and preclinical studies [89,90]. Autophagy is a key pathway through which microbial polyamines, particularly spermidine, modulate intestinal aging. By stimulating autophagic flux, spermidine enhances the clearance of damaged proteins and organelles, supports epithelial stem cell function, reinforces barrier integrity, and increases cellular resilience to inflammatory and metabolic stress. These effects are well-documented in vitro and in animal models, with emerging observational support in humans [91]. Collectively, these mechanistic actions position microbial polyamine metabolism as a central regulator of intestinal physiology during aging. Experimental evidence strongly supports roles in epithelial repair, barrier maintenance, immune modulation, and autophagy, yet direct confirmation in humans remains limited and largely observational. Further clinical and interventional studies are needed to validate the translational potential of microbial-derived polyamines for promoting healthy intestinal aging.

4.3. Dysbiosis and Pathogenic Overproduction of Harmful Polyamines

Although commensal microbes generate beneficial polyamines, dysbiosis may promote the overproduction of potentially harmful biogenic amines, including putrescine and cadaverine, which are often produced by spoilage-associated or pathogenic bacteria. These compounds typically arise from uncontrolled amino acid decarboxylation and may accumulate in the gut or in inadequately processed or stored foods [92,93]. Cadaverine, generated from lysine by microbial lysine decarboxylase (CadA/Ldc), is enriched in dysbiotic communities where it depletes lysine essential for epithelial renewal, promotes butyrate-producing microbiota, and drives barrier dysfunction and inflammatory signaling, as shown in in vitro and animal models [94,95]. In older individuals, diminished detoxification capacity and compromised intestinal barrier function can heighten susceptibility to the adverse effects of these amines, such as mucosal irritation, inflammatory responses, and systemic toxicity. These observations underscore the importance of maintaining microbial balance and implementing strict control over food fermentation and storage practices in aging populations [96].

5. Dietary Polyamines and Food Sources Relevant to Aging

5.1. Polyamine-Rich Foods

Dietary intake represents a major source of polyamines, with numerous foods naturally containing putrescine, spermidine, and spermine [97,98]. Fermented products such as yogurt, cheese, fermented vegetables, and traditional fermented foods are particularly rich due to microbial activity during fermentation [99,100]. Fruits, vegetables, mushrooms, and seafood also contribute appreciable amounts, with polyamine content influenced by species, maturity, and processing methods [101]. Food processing and storage conditions substantially affect polyamine concentrations. Factors such as heat treatment, fermentation duration, and hygienic handling can either enhance beneficial polyamine levels or favor the formation of undesirable biogenic amines, emphasizing the need for controlled processing strategies [102,103]. Dietary sources of polyamines and their relative abundance are summarized in Table 2.

5.2. Microbial Fermentation as a Natural Enrichment Strategy

Microbial fermentation provides a sustainable method for enriching foods with beneficial polyamines. Starter culture selection is crucial, as microbial strains differ markedly in their capacity to synthesize or degrade these compounds. Appropriately selected lactic acid bacteria and fermentative microbes can increase spermidine content while minimizing the accumulation of harmful amines [116,117]. From a food microbiology perspective, fermentation parameters including substrate composition, temperature, pH, and duration, strongly shape polyamine profiles. Optimization of these factors enables the production of fermented foods with enhanced safety and functional value, particularly for aging consumers [118].

5.3. Polyamines as Functional Food Components for Healthy Aging

Accumulating evidence indicates that polyamines, particularly spermidine, function as bioactive dietary components relevant to healthy aging. Higher intake of spermidine has been associated with increased lifespan and improved metabolic and cardiovascular outcomes in both experimental and observational studies. Dietary polyamines, particularly spermidine, act as functional food components that support healthy aging by promoting autophagy, enhancing intestinal and cardiovascular function, and modulating immune and metabolic homeostasis. Evidence arises from preclinical models and human observational studies [119]. Within the aging gut, polyamines modulate immune responses, promote autophagy, and support epithelial integrity [120]. These intestinal effects have been demonstrated primarily through mechanistic and preclinical studies (in vitro and animal/in vivo), highlighting how microbial polyamines support gut barrier integrity, modulate inflammation, and maintain metabolic and immune homeostasis which play major processes that decline with aging and influence susceptibility to age-related diseases [121,122]. Moreover, dietary polyamines may attenuate chronic inflammation and oxidative stress, the major drivers of intestinal and systemic aging. Evidence for the inflammation- and oxidative stress-modulating effects of polyamines is largely based on mechanistic and preclinical studies, showing regulation of reactive oxygen species, antioxidant defenses, and inflammatory signaling, with direct clinical validation still limited [123,124]. Incorporating polyamine-rich foods and carefully designed fermented products into daily diets, therefore, represents a promising functional nutrition strategy to support gut health, immune equilibrium, and overall physiological resilience in older adults [125,126]. However, human evidence remains largely observational, highlighting the need for controlled dietary intervention trials to confirm translational benefits (clinical/interventional).

5.4. Dietary Amino Acid Precursors and Substrate Availability for Microbial Polyamine Synthesis

Dietary and endogenous proteins that escape small intestinal digestion provide the principal nitrogenous substrates for microbial polyamine biosynthesis in the large intestine. Between 3 and 11 g of such proteins and peptides reaches the colon daily, where bacterial proteases and peptidases release amino acids for microbial use. Among these, arginine, ornithine, and lysine are particularly important: arginine can be converted by gut bacteria into agmatine and subsequently putrescine, ornithine serves directly as a substrate for putrescine through decarboxylation, and lysine metabolism generates cadaverine. These amino acid-dependent pathways highlight how the recycling of host-derived proteins links dietary intake, microbial metabolism, and colonic polyamine availability, supporting both microbial growth and intestinal physiological functions [127]. Aging is accompanied by physiological changes that affect protein digestion and intestinal transit, including reduced pancreatic enzyme output, altered mastication due to dentition loss, delayed gastric emptying, and slower gut motility. Consequently, a larger fraction of dietary protein reaches the colon in older adults, increasing substrate availability for microbial proteolytic fermentation. This promotes enhanced amino acid catabolism by the gut microbiota and may elevate local production of polyamines and related metabolites. Evidence from both human and animal studies indicates decreased postprandial amino acid absorption and reduced fecal protein digestion in elderly populations, reflecting combined effects of host digestive decline and age-associated shifts in microbial community composition [128].
While increased microbial polyamine synthesis can support epithelial maintenance and stress resilience under eubiotic conditions, excessive proteolytic fermentation, especially in fermented foods, can lead to the accumulation of potentially harmful biogenic amines and inflammatory by-products. Dietary strategies, including high-quality protein sources, balanced amino acid intake, and the use of plant-derived additives in fermented products, can help limit biogenic amine formation by inhibiting microbial decarboxylases and controlling microbial activity. This duality underscores the importance of combining dietary protein management with microbial regulation to optimize polyamine profiles and maintain gut health during aging [129]. Importantly, these observations suggest that microbial-derived polyamines represent a dynamic interface between diet and host physiology, complementing endogenous host synthesis and direct dietary polyamine intake in determining overall polyamine exposure during aging.

6. Biophysical and Biophysiological Actions of Polyamines in the Aging Intestine

Polyamines influence intestinal aging through fundamental biophysical and biophysiological mechanisms operating at the molecular, cellular, and tissue levels. As aging is accompanied by reduced cellular repair capacity and heightened vulnerability to stress, the structural and regulatory properties of polyamines become increasingly critical for maintaining intestinal integrity [130]. Their cationic nature enables direct interactions with negatively charged biomolecules, allowing polyamines to function as stabilizers, metabolic modulators, and signaling intermediates within aging intestinal tissues [131]. Such molecular interactions have been characterized mainly in biochemical and cellular systems (in vitro). A key molecular function of polyamines is their ability to stabilize DNA and RNA, thereby supporting cellular repair and renewal. This nucleic acid-stabilizing role is supported primarily by mechanistic and preclinical evidence (in vitro and animal/in vivo). By binding nucleic acids, polyamines reduce susceptibility to oxidative damage and structural destabilization, hallmarks of aging cells. This interaction facilitates proper chromatin organization and preserves transcriptional and translational fidelity, ultimately sustaining epithelial turnover and limiting genomic instability in the aging intestine [132].
It is important to recognize that the biological effects of polyamines in the aging intestine result from the combined contributions of host synthesis, dietary intake, and microbial production, each with context-dependent roles. Host-derived polyamines maintain systemic and intracellular pools essential for basal cellular functions, including proliferation, differentiation, and tissue maintenance, while dietary polyamines absorbed primarily in the upper gastrointestinal tract, support circulating and tissue-associated levels. Emerging evidence also suggests that these integrated polyamine sources may influence age-related conditions, such as bone loss, sarcopenia, and epithelial decline, highlighting their broader significance in healthy aging [133]. In contrast, microbially derived polyamines are produced locally in the colon, where they act primarily on colonic epithelial cells and mucosal immune components to maintain barrier integrity and epithelial–microbiota homeostasis. This localized contribution becomes increasingly important during aging, when reduced digestive efficiency, shifts in microbial composition, and declining epithelial resilience heighten reliance on microbiota-mediated polyamine production for intestinal stability [134].
Polyamines, particularly spermidine, also play a pivotal role in restoring autophagic activity, which declines with age. Spermidine-induced autophagy has been consistently demonstrated in vitro and in animal models, where it preserves cellular and tissue homeostasis, and its relevance is indirectly supported by human observational studies linking autophagy dysfunction to a wide range of age-related disorders, including cardiovascular, neurodegenerative, metabolic, and musculoskeletal diseases [135]. By modulating epigenetic regulators and nutrient-sensing pathways, spermidine enhances the clearance of damaged proteins and organelles. In intestinal epithelial cells, this autophagic activation promotes barrier renewal, supports stem cell function, and improves resistance to inflammatory and metabolic stress, thereby contributing to tissue homeostasis during aging [136,137]. These intestinal outcomes have not yet been conclusively confirmed in clinical intervention studies. At the level of the epithelial barrier, polyamines reinforce membrane stability and tight junction integrity. This effect has been demonstrated primarily in well-controlled experimental intestinal models, including in vitro and animal studies, which provide mechanistic insights into gut functionality, epithelial health, and host–microbiota interactions [138]. Their interactions with membrane phospholipids enhance bilayer organization and reduce oxidative vulnerability, while their regulatory effects on cytoskeletal dynamics support tight junction assembly and maintenance. These actions are particularly relevant in older individuals, in whom increased intestinal permeability is associated with chronic inflammation and systemic metabolic disturbances [139,140].
Polyamines further contribute to mitochondrial preservation by stabilizing mitochondrial membranes, supporting efficient oxidative phosphorylation, and limiting excessive generation of reactive oxygen species. Through these mechanisms, they help maintain cellular energy balance and protect epithelial cells from oxidative injury. Evidence for mitochondrial protection is derived primarily from in vitro and animal studies, which demonstrate how interventions can preserve mitochondrial structure, regulate bioenergetics, and prevent dysfunction associated with aging and disease, including neurodegenerative, cardiovascular, metabolic, and cancer-related conditions [141]. In parallel, polyamines influence inflammatory signaling by modulating redox-sensitive pathways and cytokine networks, thereby dampening low-grade chronic inflammation commonly observed in aging intestines [142,143]. These anti-inflammatory effects are supported mainly by preclinical data. Crucially, polyamines intersect with key longevity-associated signaling pathways, such as mTOR and AMPK. Regulation of immune and autophagy-related pathways by spermidine has been demonstrated primarily in experimental models, where it promotes CD4+ T-cell differentiation toward regulatory phenotypes in vitro and enhances gut Treg cell populations in mice, with protective effects that depend on intact autophagic machinery [144]. By attenuating mTOR activity and promoting AMPK signaling, spermidine supports metabolic flexibility, stress adaptation, and autophagy induction. This coordinated regulation of nutrient-sensing pathways enables intestinal cells to better adapt to age-related metabolic challenges [145]. Figure 3 depicts the biophysical mechanisms of polyamine action at cellular and molecular levels, including their interactions with nucleic acids, membranes, ion channels, and protein synthesis machinery. The mechanisms illustrated are derived predominantly from preclinical studies. The influence of polyamines on established biomarkers of intestinal aging is presented in Table 3.

7. Diet–Microbiota–Polyamine Interactions in Intestinal Aging

Intestinal polyamine availability in older adults emerges from a dynamic interplay between dietary intake, microbial metabolism, and host physiology [159]. This integrative concept is supported primarily by mechanistic animal studies and human observational data, as controlled interventions remain limited and often do not account for sex-specific differences in microbiota-mediated metabolic and immunological responses during aging [160]. Dietary patterns strongly shape microbial composition and functional capacity, determining the extent to which gut microbes synthesize and transform polyamines [161]. Most evidence for diet-driven modulation of microbial polyamine production comes from animal studies and human observational cohorts (in vivo and observational). While dietary changes can rapidly shift gut microbial composition, such taxonomic alterations do not always translate to changes in metabolic function; emerging data suggest that polyamine biosynthesis and other microbial activities can vary independently of bacterial abundance, with implications for host metabolic and immune health [162]. Polyamines produced by certain bacterial strains can be secreted into the intestinal lumen and used by other microbes that lack the biosynthetic capacity to produce them, highlighting metabolic cross-feeding. Beyond basic cellular roles, microbial polyamines also contribute to biofilm formation, stress resistance, bacteriocin and toxin activity, and survival within hostile environments, emphasizing their multifaceted functional significance in the gut ecosystem [163]. During aging, disruptions in these cooperative metabolic interactions may exert greater functional consequences than compositional alterations alone, leading to impaired polyamine availability despite relatively preserved microbial diversity. Diets rich in plant-based foods, fermentable substrates, and traditional fermented products favor microbial communities capable of sustaining polyamine production [164]. These interactions operate through reciprocal feedback mechanisms in which microbial-derived polyamines enhance epithelial barrier function and immune regulation, thereby creating a favorable niche for beneficial microbiota. Such feedback mechanisms have been demonstrated primarily in experimental models (in vitro and animal/in vivo), where polyamines have been shown to mediate key processes in cell growth, differentiation, and stress responses. Insights from plant studies, particularly in Arabidopsis thaliana, highlight the essential role of polyamines in embryogenesis and organogenesis, emphasizing their tightly regulated spatial and temporal activity [165]. Disruption of this axis through dietary insufficiency or microbiota imbalance can weaken polyamine-mediated protection and accelerate intestinal aging. This integrated framework highlights diet as a modifiable factor for restoring microbial polyamine metabolism and supporting intestinal resilience in later life. Figure 4 summarizes the diet–microbiota–polyamine axis, demonstrating how dietary substrates, microbial metabolism, and host regulatory pathways converge to influence polyamine homeostasis and health outcomes. Human intervention studies validating this axis remain limited.

8. Safety Considerations, Toxicology, and Food Industry Relevance

Although physiologically essential, excessive accumulation of certain polyamines and biogenic amines poses toxicological risks, particularly for elderly individuals with diminished metabolic clearance and compromised gut barriers. Evidence for adverse effects of biogenic amines arises primarily from toxicological studies and clinical observations rather than controlled dietary trials. High concentrations of histamine, tyramine, and putrescine in foods can cause intoxication, with symptoms influenced by dose and potential synergistic interactions, underscoring the need for risk assessment and regulation [166]. Elevated exposure may provoke gastrointestinal irritation, inflammatory responses, or systemic effects, emphasizing the need to define safe intake thresholds for aging populations [167]. In food systems, polyamine levels also serve as markers of microbial activity and product quality. This application is supported by food microbiology and analytical research, including in vitro studies and industrial-scale observations, demonstrating that microbial fermentation, bioproducts, and biotransformation processes enhance food safety, nutritional functionality, and shelf life in sustainable food systems [168]. High concentrations of putrescine and cadaverine are frequently associated with spoilage and inadequate hygienic practices, especially in protein-rich and fermented foods. Consequently, polyamine profiling is increasingly recognized as a valuable tool for assessing food safety and freshness [169]. Regulatory oversight of polyamine content remains inconsistent across regions. Advances in analytical technologies, including chromatographic and sensor-based detection methods, have improved the accuracy of monitoring polyamine levels. These technologies have been validated primarily in laboratory and industrial settings rather than clinical contexts. Incorporating these tools into food safety frameworks will be essential for maximizing functional benefits while minimizing health risks [170]. It is important to distinguish between physiologically beneficial polyamines, such as spermidine, spermine, and agmatine, which support epithelial renewal, barrier integrity, and immunomodulation, and potentially harmful biogenic amines, including putrescine and cadaverine when produced in excess or during dysbiosis. Beneficial polyamines enhance intestinal resilience by supporting epithelial regeneration, proteostasis, and protein synthesis, and, as demonstrated in vivo in old mice, dietary or microbial modulation of polyamine pathways can restore age-related declines in tissue repair, highlighting their potential to promote healthy intestinal aging [171], whereas toxic biogenic amines can build up when fermentation is poorly controlled, food spoils, or certain microbes with amino acid-decarboxylating activity overgrow, potentially triggering inflammation, epithelial damage, and adverse health effects [172,173]. This dual perspective emphasizes the need for balanced microbial activity, careful selection of fermentation processes, and monitoring of polyamine content in foods to optimize both safety and functional benefits. A distinction between beneficial and toxic polyamines relevant to food systems is provided in Table 4.

9. Research Gaps and Emerging Opportunities

Despite substantial experimental evidence, human data on polyamine supplementation and dietary intake in aging populations remain limited. Future clinical studies should prioritize elderly cohorts and integrate microbiome, metabolomic, and functional health outcomes to establish evidence-based recommendations. Food innovation strategies aimed at optimizing polyamine profiles through controlled fermentation, processing, and storage are also needed. Additionally, the development of probiotic strains with targeted polyamine-producing capabilities presents a promising avenue for functional nutrition. At the mechanistic level, advanced biophysical approaches, including molecular modeling and simulation studies, may further elucidate polyamine interactions with membranes, nucleic acids, and signaling proteins, strengthening translational relevance.

10. Conclusions

Polyamines play a central role in preserving intestinal structure and function during aging through coordinated molecular, metabolic, and signaling mechanisms. As endogenous synthesis declines with age, dietary sources and microbial metabolism become critical determinants of polyamine availability. Mechanistic insights demonstrate that polyamines support nucleic acid stability, autophagy, epithelial barrier integrity, mitochondrial function, and immune balance, processes fundamental to intestinal repair and resilience. These findings underscore the potential of polyamine-focused dietary and microbial strategies for developing functional foods tailored to aging populations. By integrating perspectives from food science, microbiology, and biophysiology, polyamines emerge as key modulators of intestinal aging and as promising targets for nutritional interventions that promote healthy longevity.

Author Contributions

Conceptualization, A.N.M. and D.B.; methodology, A.N.M.; software, A.N.M.; validation, D.B.; investigation, A.N.M.; writing—original draft preparation, A.N.M.; writing—review and editing, A.N.M. and D.B.; visualization, A.N.M. and D.B.; supervision, D.B.; project administration, D.B.; and funding acquisition, D.B. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Priorities Research Program grant NPRP 14S0311–210033, awarded to Dietrich Büsselberg (January 2023–Current) from the Qatar National Research Fund (QNRF, a member of the Qatar Foundation). The publication of this work was funded by the Qatar Health Sciences Library, Weill Cornell Medicine. The statements made herein are solely the responsibility of the authors.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

We gratefully acknowledge and appreciate the Qatar Health Sciences Library, Weill Cornell Medicine for covering the publication costs. The views expressed in this article are solely the Author’s responsibility.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
AMPKAdenosine Monophosphate-Activated Protein Kinase
DNADeoxyribonucleic Acid
LABLactic Acid Bacteria
mTORMechanistic Target of Rapamycin
NF-κBNuclear Factor Kappa B
ODCOrnithine Decarboxylase
RNARibonucleic Acid
ROSReactive Oxygen Species

References

  1. Sagar, N.A.; Tarafdar, S.; Agarwal, S.; Tarafdar, A.; Sharma, S. Polyamines: Functions, Metabolism, and Role in Human Disease Management. Med. Sci. 2021, 9, 44. [Google Scholar] [CrossRef]
  2. Chen, D.; Shao, Q.; Yin, L.; Younis, A.; Zheng, B. Polyamine Function in Plants: Metabolism, Regulation on Development, and Roles in Abiotic Stress Responses. Front. Plant Sci. 2019, 9, 1945. [Google Scholar] [CrossRef]
  3. Schibalski, R.S.; Shulha, A.S.; Tsao, B.P.; Palygin, O.; Ilatovskaya, D.V. The role of polyamine metabolism in cellular function and physiology. Am. J. Physiol. Physiol. 2024, 327, C341–C356. [Google Scholar] [CrossRef]
  4. Xuan, M.; Gu, X.; Li, J.; Huang, D.; Xue, C.; He, Y. Polyamines: Their significance for maintaining health and contributing to diseases. Cell Commun. Signal. 2023, 21, 348. [Google Scholar] [CrossRef]
  5. Rao, J.N.; Xiao, L.; Wang, J.-Y. Polyamines in Gut Epithelial Renewal and Barrier Function. Physiology 2020, 35, 328–337. [Google Scholar] [CrossRef]
  6. Nakamura, A.; Matsumoto, M. Role of polyamines in intestinal mucosal barrier function. Semin. Immunopathol. 2025, 47, 9. [Google Scholar] [CrossRef]
  7. Li, X.; Xiao, X.; Wang, S.; Wu, B.; Zhou, Y.; Deng, P. Uncovering de novo polyamine biosynthesis in the gut microbiome and its alteration in inflammatory bowel disease. Gut Microbes 2025, 17, 2464225. [Google Scholar] [CrossRef] [PubMed]
  8. Shi, Y.; Zheng, H.; Zhu, X.; Lv, J.; Zhou, M.; Zhang, S. Aging and Intestinal Fibrosis: Mechanisms, Implications, and Therapeutic Strategies. Clin. Interv. Aging 2025, 20, 2177–2194. [Google Scholar] [CrossRef] [PubMed]
  9. Wang, Y.; Zhang, X.; Qing, M.; Dang, W.; Bai, X.; Wang, Y.; Zhou, D.; Zhu, L.; Qing, D.; Zhang, J.; et al. Trends in intestinal aging: From underlying mechanisms to therapeutic strategies. Acta Pharm. Sin. B 2025, 15, 3372–3403. [Google Scholar] [CrossRef]
  10. Tseng, C.-H.; Wu, C.-Y. From dysbiosis to longevity: A narrative review into the gut microbiome’s impact on aging. J. Biomed. Sci. 2025, 32, 93. [Google Scholar] [CrossRef] [PubMed]
  11. Pellanda, P.; Ghosh, T.S.; O’Toole, P.W. Understanding the impact of age-related changes in the gut microbiome on chronic diseases and the prospect of elderly-specific dietary interventions. Curr. Opin. Biotechnol. 2021, 70, 48–55. [Google Scholar] [CrossRef] [PubMed]
  12. Tofalo, R.; Cocchi, S.; Suzzi, G. Polyamines and Gut Microbiota. Front. Nutr. 2019, 6, 16. [Google Scholar] [CrossRef]
  13. Zhang, C.; Zhen, Y.; Weng, Y.; Lin, J.; Xu, X.; Ma, J.; Zhong, Y.; Wang, M. Research progress on the microbial metabolism and transport of polyamines and their roles in animal gut homeostasis. J. Anim. Sci. Biotechnol. 2025, 16, 57. [Google Scholar] [CrossRef]
  14. Han, Z.; Zhao, L.; Hu, Q.; Hung, I.; Liu, C.; Liu, S.; Mei, X.; Zeng, X.; Bin, P.; Wang, J. Gut microbiota-mediated modulation of host amino acid availability and metabolism. Gut Microbes 2025, 17, 2552345. [Google Scholar] [CrossRef]
  15. Gou, H.; Zeng, R.; Lau, H.C.H.; Yu, J. Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer. Pharmacol. Res. 2024, 208, 107373. [Google Scholar] [CrossRef] [PubMed]
  16. Nakamura, A.; Kurihara, S.; Takahashi, D.; Ohashi, W.; Nakamura, Y.; Kimura, S.; Onuki, M.; Kume, A.; Sasazawa, Y.; Furusawa, Y.; et al. Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon. Nat. Commun. 2021, 12, 2105. [Google Scholar] [CrossRef] [PubMed]
  17. Romaní-Pérez, M.; Bullich-Vilarrubias, C.; López-Almela, I.; Liébana-García, R.; Olivares, M.; Sanz, Y. The Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis. Int. J. Mol. Sci. 2021, 22, 5830. [Google Scholar] [CrossRef]
  18. Muigano, M.N.; Liu, J.; Liu, X.; Luo, P.; Li, Z.; Li, J. The Impact of Dietary Patterns on the Human Gut Microbiome and Its Health Significance: A Review. FASEB J. 2025, 39, e71072. [Google Scholar] [CrossRef]
  19. Ballini, A.; Charitos, I.A.; Cantore, S.; Topi, S.; Bottalico, L.; Santacroce, L. About Functional Foods: The Probiotics and Prebiotics State of Art. Antibiotics 2023, 12, 635. [Google Scholar] [CrossRef]
  20. Terpou, A.; Dahiya, D.; Nigam, P.S. Evolving Dynamics of Fermented Food Microbiota and the Gut Microenvironment: Strategic Pathways to Enhance Human Health. Foods 2025, 14, 2361. [Google Scholar] [CrossRef]
  21. Killiny, N.; Nehela, Y. Citrus Polyamines: Structure, Biosynthesis, and Physiological Functions. Plants 2020, 9, 426. [Google Scholar] [CrossRef] [PubMed]
  22. Bekebrede, A.F.; Keijer, J.; Gerrits, W.J.J.; de Boer, V.C.J. The Molecular and Physiological Effects of Protein-Derived Polyamines in the Intestine. Nutrients 2020, 12, 197. [Google Scholar] [CrossRef]
  23. Jimenez Gutierrez, G.E.; Borbolla Jiménez, F.V.; Muñoz, L.G.; Tapia Guerrero, Y.S.; Murillo Melo, N.M.; Cristóbal-Luna, J.M.; Leyva Garcia, N.; Cordero-Martínez, J.; Magaña, J.J. The Molecular Role of Polyamines in Age-Related Diseases: An Update. Int. J. Mol. Sci. 2023, 24, 16469. [Google Scholar] [CrossRef]
  24. Rieck, J.; Skatchkov, S.N.; Derst, C.; Eaton, M.J.; Veh, R.W. Unique Chemistry, Intake, and Metabolism of Polyamines in the Central Nervous System (CNS) and Its Body. Biomolecules 2022, 12, 501. [Google Scholar] [CrossRef]
  25. Chang, L.; Li, Z.; Guo, H.; Zhang, W.; Lan, W.; Wang, J.; Shen, G.; Xia, Q.; Zhao, P. Function of Polyamines in Regulating Cell Cycle Progression of Cultured Silkworm Cells. Insects 2021, 12, 624. [Google Scholar] [CrossRef]
  26. Zahedi, K.; Barone, S.; Soleimani, M. Polyamines and Their Metabolism: From the Maintenance of Physiological Homeostasis to the Mediation of Disease. Med. Sci. 2022, 10, 38. [Google Scholar] [CrossRef]
  27. Brooks, W.H. Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease. J. Alzheimer’s Dis. 2024, 98, 837–857. [Google Scholar] [CrossRef]
  28. Sánchez-Jiménez, F.; Medina, M.Á.; Villalobos-Rueda, L.; Urdiales, J.L. Polyamines in mammalian pathophysiology. Cell. Mol. Life Sci. 2019, 76, 3987–4008. [Google Scholar] [CrossRef] [PubMed]
  29. Tan, B.; Xiao, D.; Wang, J.; Tan, B. The Roles of Polyamines in Intestinal Development and Function in Piglets. Animals 2024, 14, 1228. [Google Scholar] [CrossRef]
  30. Wu, C.-G.; Tian, J.-L.; Liu, R.; Cao, P.-F.; Zhang, T.-J.; Ren, A.; Shi, L.; Zhao, M.-W. Ornithine Decarboxylase-Mediated Production of Putrescine Influences Ganoderic Acid Biosynthesis by Regulating Reactive Oxygen Species in Ganoderma lucidum. Appl. Environ. Microbiol. 2017, 83, e01289-17. [Google Scholar] [CrossRef] [PubMed]
  31. Ávila, C.; Llebrés, M.T.; Cánovas, F.M.; Castro-Rodríguez, V. Arginine, a key amino acid for nitrogen nutrition and metabolism of forest trees. J. Exp. Bot. 2025, 76, 5238–5251. [Google Scholar] [CrossRef] [PubMed]
  32. Martí i Líndez, A.-A.; Reith, W. Arginine-dependent immune responses. Cell. Mol. Life Sci. 2021, 78, 5303–5324. [Google Scholar] [CrossRef]
  33. Zhu, M. Expression of human arginine decarboxylase, the biosynthetic enzyme for agmatine. Biochim. Biophys. Acta-Gen. Subj. 2004, 1670, 156–164. [Google Scholar] [CrossRef]
  34. Sandoval, M.; Shah, D.D. Diversity and distribution of amino acid decarboxylase enzymes in the human gut bacteria—A bioinformatics investigation. Front. Microbiol. 2025, 16, 1616635. [Google Scholar] [CrossRef]
  35. Ramos-Molina, B.; Queipo-Ortuño, M.I.; Lambertos, A.; Tinahones, F.J.; Peñafiel, R. Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases. Front. Nutr. 2019, 6, 24. [Google Scholar] [CrossRef]
  36. Ding, S.; Yan, W.; Ma, Y.; Fang, J. The impact of probiotics on gut health via alternation of immune status of monogastric animals. Anim. Nutr. 2021, 7, 24–30. [Google Scholar] [CrossRef] [PubMed]
  37. Mokoena, M.P. Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review. Molecules 2017, 22, 1255. [Google Scholar] [CrossRef] [PubMed]
  38. Huang, R.; Wu, F.; Zhou, Q.; Wei, W.; Yue, J.; Xiao, B.; Luo, Z. Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications. Microbiol. Res. 2022, 260, 127019. [Google Scholar] [CrossRef]
  39. Greenwood, M.P.; Greenwood, M.; Paton, J.F.R.; Murphy, D. Control of Polyamine Biosynthesis by Antizyme Inhibitor 1 Is Important for Transcriptional Regulation of Arginine Vasopressin in the Male Rat Hypothalamus. Endocrinology 2015, 156, 2905–2917. [Google Scholar] [CrossRef]
  40. Zare, D.; Aryaee, H.; Mirdamadi, S.; Shirkhan, F. The Benefits and Applications of Lactobacillus plantarum in Food and Health: A Narrative Review. Iran. J. Public Health 2024, 53, 2201–2213. [Google Scholar] [CrossRef]
  41. Popova-Krumova, P.; Danova, S.; Atanasova, N.; Yankov, D. Lactic Acid Production by Lactiplantibacillus plantarum AC 11S—Kinetics and Modeling. Microorganisms 2024, 12, 739. [Google Scholar] [CrossRef]
  42. Xiao, M.; Zhang, C.; Duan, H.; Narbad, A.; Zhao, J.; Chen, W.; Zhai, Q.; Yu, L.; Tian, F. Cross-feeding of bifidobacteria promotes intestinal homeostasis: A lifelong perspective on the host health. NPJ Biofilms Microbiomes 2024, 10, 47. [Google Scholar] [CrossRef]
  43. Ramos, S.; Silva, V.; Dapkevicius, M.; Igrejas, G.; Poeta, P. Enterococci, from Harmless Bacteria to a Pathogen. Microorganisms 2020, 8, 1118. [Google Scholar] [CrossRef]
  44. Krawczyk, B.; Wityk, P.; Gałęcka, M.; Michalik, M. The Many Faces of Enterococcus spp.—Commensal, Probiotic and Opportunistic Pathogen. Microorganisms 2021, 9, 1900. [Google Scholar] [CrossRef] [PubMed]
  45. Raman, J.; Noh, J.S.; Kim, J.-S.; Cho, G.; Kim, D.-H.; Song, J.; Kim, S.-J. Role of Bacillus Species in Food Industry: Advantages and Limitations. J. Microbiol. Biotechnol. 2025, 35, e2507043. [Google Scholar] [CrossRef]
  46. Choi, G.H.; Fugaban, J.I.I.; Dioso, C.M.; Vazquez Bucheli, J.E.; Holzapfel, W.H.; Todorov, S.D. Selection of Bacteriocinogenic Bacillus spp. from Traditional Fermented Korean Food Products with Additional Beneficial Properties. Fermentation 2021, 7, 271. [Google Scholar] [CrossRef]
  47. Rau, M.H.; Gaspar, P.; Jensen, M.L.; Geppel, A.; Neves, A.R.; Zeidan, A.A. Genome-Scale Metabolic Modeling Combined with Transcriptome Profiling Provides Mechanistic Understanding of Streptococcus thermophilus CH8 Metabolism. Appl. Environ. Microbiol. 2022, 88, e0078022. [Google Scholar] [CrossRef]
  48. Wang, Y.; Wu, J.; Lv, M.; Shao, Z.; Hungwe, M.; Wang, J.; Bai, X.; Xie, J.; Wang, Y.; Geng, W. Metabolism Characteristics of Lactic Acid Bacteria and the Expanding Applications in Food Industry. Front. Bioeng. Biotechnol. 2021, 9, 612285. [Google Scholar] [CrossRef] [PubMed]
  49. Chandra, H.; Sharma, K.K.; Tuovinen, O.H.; Sun, X.; Shukla, P. Pathobionts: Mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile. Gut Microbes 2021, 13, 1979882. [Google Scholar] [CrossRef] [PubMed]
  50. Borrego-Ruiz, A.; González-Domenech, C.M.; Borrego, J.J. The Role of Fermented Vegetables as a Sustainable and Health-Promoting Nutritional Resource. Appl. Sci. 2024, 14, 10853. [Google Scholar] [CrossRef]
  51. Doeun, D.; Davaatseren, M.; Chung, M.-S. Biogenic amines in foods. Food Sci. Biotechnol. 2017, 26, 1463–1474. [Google Scholar] [CrossRef] [PubMed]
  52. Visciano, P.; Schirone, M. Update on Biogenic Amines in Fermented and Non-Fermented Beverages. Foods 2022, 11, 353. [Google Scholar] [CrossRef]
  53. Voidarou, C.; Antoniadou, Μ.; Rozos, G.; Tzora, A.; Skoufos, I.; Varzakas, T.; Lagiou, A.; Bezirtzoglou, E. Fermentative Foods: Microbiology, Biochemistry, Potential Human Health Benefits and Public Health Issues. Foods 2020, 10, 69. [Google Scholar] [CrossRef] [PubMed]
  54. Bushra, R.; Aslam, N.; Khan, A. Food Drug Interactions. Oman Med. J. 2011, 26, 77–83. [Google Scholar] [CrossRef] [PubMed]
  55. Peivasteh-roudsari, L.; Barzegar-bafrouei, R.; Sharifi, K.A.; Azimisalim, S.; Karami, M.; Abedinzadeh, S.; Asadinezhad, S.; Tajdar-oranj, B.; Mahdavi, V.; Alizadeh, A.M.; et al. Origin, dietary exposure, and toxicity of endocrine-disrupting food chemical contaminants: A comprehensive review. Heliyon 2023, 9, e18140. [Google Scholar] [CrossRef]
  56. Zapaśnik, A.; Sokołowska, B.; Bryła, M. Role of Lactic Acid Bacteria in Food Preservation and Safety. Foods 2022, 11, 1283. [Google Scholar] [CrossRef]
  57. Medina, M.Á.; Urdiales, J.L.; Rodríguez-Caso, C.; Ramírez, F.J.; Sánchez-Jiménez, F. Biogenic Amines and Polyamines: Similar Biochemistry for Different Physiological Missions and Biomedical Applications. Crit. Rev. Biochem. Mol. Biol. 2003, 38, 23–59. [Google Scholar] [CrossRef]
  58. Sander, T.; Farke, N.; Diehl, C.; Kuntz, M.; Glatter, T.; Link, H. Allosteric Feedback Inhibition Enables Robust Amino Acid Biosynthesis in E. coli by Enforcing Enzyme Overabundance. Cell Syst. 2019, 8, 66–75.e8. [Google Scholar] [CrossRef]
  59. Vale, N.; Ferreira, A.; Matos, J.; Fresco, P.; Gouveia, M.J. Amino Acids in the Development of Prodrugs. Molecules 2018, 23, 2318. [Google Scholar] [CrossRef]
  60. Naz, S.; Liu, P.; Farooq, U.; Ma, H. Insight into de-regulation of amino acid feedback inhibition: A focus on structure analysis method. Microb. Cell Fact. 2023, 22, 161. [Google Scholar] [CrossRef]
  61. Dalangin, R.; Kim, A.; Campbell, R.E. The Role of Amino Acids in Neurotransmission and Fluorescent Tools for Their Detection. Int. J. Mol. Sci. 2020, 21, 6197. [Google Scholar] [CrossRef]
  62. Abankwah, J.K.; Wang, Y.; Wang, J.; Ogbe, S.E.; Pozzo, L.D.; Chu, X.; Bian, Y. Gut aging: A wane from the normal to repercussion and gerotherapeutic strategies. Heliyon 2024, 10, e37883. [Google Scholar] [CrossRef]
  63. Funk, M.C.; Zhou, J.; Boutros, M. Ageing, metabolism and the intestine. EMBO Rep. 2020, 21, e50047. [Google Scholar] [CrossRef] [PubMed]
  64. Ma, G.; Chen, Z.; Xie, Z.; Liu, J.; Xiao, X. Mechanisms underlying changes in intestinal permeability during pregnancy and their implications for maternal and infant health. J. Reprod. Immunol. 2025, 168, 104423. [Google Scholar] [CrossRef] [PubMed]
  65. Walrath, T.; Dyamenahalli, K.U.; Hulsebus, H.J.; McCullough, R.L.; Idrovo, J.-P.; Boe, D.M.; McMahan, R.H.; Kovacs, E.J. Age-related changes in intestinal immunity and the microbiome. J. Leukoc. Biol. 2021, 109, 1045–1061. [Google Scholar] [CrossRef] [PubMed]
  66. Cornick, S.; Tawiah, A.; Chadee, K. Roles and regulation of the mucus barrier in the gut. Tissue Barriers 2015, 3, e982426. [Google Scholar] [CrossRef]
  67. Sang, X.; Wang, Q.; Ning, Y.; Wang, H.; Zhang, R.; Li, Y.; Fang, B.; Lv, C.; Zhang, Y.; Wang, X.; et al. Age-Related Mucus Barrier Dysfunction in Mice Is Related to the Changes in Muc2 Mucin in the Colon. Nutrients 2023, 15, 1830. [Google Scholar] [CrossRef]
  68. Lakshminarayanan, B.; Stanton, C.; O’Toole, P.W.; Ross, R.P. Compositional dynamics of the human intestinal microbiota with aging: Implications for health. J. Nutr. Heal. Aging 2014, 18, 773–786. [Google Scholar] [CrossRef]
  69. Nagpal, R.; Mainali, R.; Ahmadi, S.; Wang, S.; Singh, R.; Kavanagh, K.; Kitzman, D.W.; Kushugulova, A.; Marotta, F.; Yadav, H. Gut microbiome and aging: Physiological and mechanistic insights. Nutr. Heal. Aging 2018, 4, 267–285. [Google Scholar] [CrossRef]
  70. Haran, J.P.; McCormick, B.A. Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease. Gastroenterology 2021, 160, 507–523. [Google Scholar] [CrossRef]
  71. Uemura, T.; Terui, Y. Special Issue “Polyamines in Aging and Disease”. Int. J. Mol. Sci. 2024, 25, 11960. [Google Scholar] [CrossRef]
  72. Green, D.R. Polyamines and Aging: A CLEAR Connection? Mol. Cell 2019, 76, 5–7. [Google Scholar] [CrossRef]
  73. Muñoz-Esparza, N.C.; Latorre-Moratalla, M.L.; Comas-Basté, O.; Toro-Funes, N.; Veciana-Nogués, M.T.; Vidal-Carou, M.C. Polyamines in Food. Front. Nutr. 2019, 6, 108. [Google Scholar] [CrossRef] [PubMed]
  74. Muñoz-Esparza, N.C.; Costa-Catala, J.; Comas-Basté, O.; Toro-Funes, N.; Latorre-Moratalla, M.L.; Veciana-Nogués, M.T.; Vidal-Carou, M.C. Occurrence of Polyamines in Foods and the Influence of Cooking Processes. Foods 2021, 10, 1752. [Google Scholar] [CrossRef]
  75. Bui, T.I.; Britt, E.A.; Muthukrishnan, G.; Gill, S.R. Probiotic induced synthesis of microbiota polyamine as a nutraceutical for metabolic syndrome and obesity-related type 2 diabetes. Front. Endocrinol. 2023, 13, 1094258. [Google Scholar] [CrossRef] [PubMed]
  76. Chen, Y.; Fang, J.-Y. The role of colonic microbiota amino acid metabolism in gut health regulation. Cell Insight 2025, 4, 100227. [Google Scholar] [CrossRef] [PubMed]
  77. Akpoghelie, P.O.; Edo, G.I.; Mafe, A.N.; Isoje, E.F.; Igbuku, U.A.; Ali, A.B.M.; Yousif, E.; Owheruo, J.O.; Oberhiri Oberhiri, S.; Essaghah, A.E.A.; et al. Food, Health, and Environmental Impact of Lactic Acid Bacteria: The Superbacteria for Posterity. Probiotics Antimicrob. Proteins 2025, 17, 2819–2855. [Google Scholar] [CrossRef]
  78. Makut, M.D.; Mafe, A.N.; Owuna, J.E.; Calina, D.; Sharifi-Rad, J. Postbiotics from indigenous lactic acid bacteria: Mechanisms, biopreservation and functional food applications. J. Sci. Food Agric. 2026; ahead of print. [Google Scholar] [CrossRef]
  79. Mafe, A.N.; Edo, G.I.; Majeed, O.S.; Gaaz, T.S.; Akpoghelie, P.O.; Isoje, E.F.; Igbuku, U.A.; Owheruo, J.O.; Opiti, R.A.; Garba, Y.; et al. A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses. Food Chem. Adv. 2025, 6, 100919. [Google Scholar] [CrossRef]
  80. Mafe, A.N.; Nkene, I.H.; Ali, A.B.M.; Edo, G.I.; Akpoghelie, P.O.; Yousif, E.; Isoje, E.F.; Igbuku, U.A.; Ismael, S.A.; Essaghah, A.E.A.; et al. Smart Probiotic Solutions for Mycotoxin Mitigation: Innovations in Food Safety and Sustainable Agriculture. Probiotics Antimicrob. Proteins, 2025; ahead of print. [Google Scholar] [CrossRef]
  81. Zielińska, D.; Kolożyn-Krajewska, D. Food-Origin Lactic Acid Bacteria May Exhibit Probiotic Properties: Review. Biomed Res. Int. 2018, 2018, 5063185. [Google Scholar] [CrossRef]
  82. Xiao, Y.; Feng, Y.; Zhao, J.; Chen, W.; Lu, W. Achieving healthy aging through gut microbiota-directed dietary intervention: Focusing on microbial biomarkers and host mechanisms. J. Adv. Res. 2025, 68, 179–200. [Google Scholar] [CrossRef] [PubMed]
  83. O’Callaghan, A.; van Sinderen, D. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front. Microbiol. 2016, 7, 925. [Google Scholar] [CrossRef]
  84. Nair, A.V.; Singh, A.; Chakravortty, D. Defence Warriors: Exploring the crosstalk between polyamines and oxidative stress during microbial pathogenesis. Redox Biol. 2025, 83, 103648. [Google Scholar] [CrossRef]
  85. Chatterjee, S.; Hebbani, A.V.; Syed, K. Gut Microbiota: An Ally in the Mechanisms and Interventions of Healthy Aging. Gastrointest. Disord. 2025, 7, 68. [Google Scholar] [CrossRef]
  86. Minetti, A.; Omrani, O.; Brenner, C.; Allies, G.; Imada, S.; Rösler, J.; Khawaled, S.; Cansiz, F.; Meckelmann, S.W.; Gebert, N.; et al. Polyamines sustain epithelial regeneration in aged intestines by modulating protein homeostasis. bioRxiv 2024. [Google Scholar] [CrossRef]
  87. Ferris, M.M.; Subitoni Antonio, L.; Al-Sadi, R. Probiotics and the intestinal tight junction barrier function. Front. Cell Dev. Biol. 2025, 13, 1671152. [Google Scholar] [CrossRef]
  88. Liu, L.; Guo, X.; Rao, J.N.; Zou, T.; Xiao, L.; Yu, T.; Timmons, J.A.; Turner, D.J.; Wang, J.-Y. Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function. Am. J. Physiol. Physiol. 2009, 296, C801–C810. [Google Scholar] [CrossRef] [PubMed]
  89. Zeng, L.; Qian, Y.; Cui, X.; Zhao, J.; Ning, Z.; Cha, J.; Wang, K.; Ge, C.; Jia, J.; Dou, T.; et al. Immunomodulatory role of gut microbial metabolites: Mechanistic insights and therapeutic frontiers. Front. Microbiol. 2025, 16, 1675065. [Google Scholar] [CrossRef]
  90. Aziz, S.; Ahmed, A.; Singh, P.; Mukhopadhyay, S. The arginase-polyamine signaling axis in immune cells: Implications for immune modulation and host-pathogen interactions. iScience 2026, 29, 114363. [Google Scholar] [CrossRef] [PubMed]
  91. Righes, G.; Semenzato, L.; Koutsikos, K.; Zanato, V.; Pinton, P.; Giorgi, C.; Patergnani, S. The role of autophagy in the pathogenesis and treatment of multiple sclerosis. Autophagy Rep. 2025, 4, 2529196. [Google Scholar] [CrossRef]
  92. Barbieri, F.; Montanari, C.; Gardini, F.; Tabanelli, G. Biogenic Amine Production by Lactic Acid Bacteria: A Review. Foods 2019, 8, 17. [Google Scholar] [CrossRef]
  93. Pawul-Gruba, M.; Denis, E.; Kiljanek, T.; Osek, J. Prevalence of Biogenic Amines and Their Relation to the Bacterial Content in Ripened Cheeses on the Retail Market in Poland. Foods 2025, 14, 2478. [Google Scholar] [CrossRef]
  94. Levine, M.; Lohinai, Z.M. Resolving the Contradictory Functions of Lysine Decarboxylase and Butyrate in Periodontal and Intestinal Diseases. J. Clin. Med. 2021, 10, 2360. [Google Scholar] [CrossRef]
  95. Zhou, N.; Zhang, A.; Wei, G.; Yang, S.; Xu, S.; Chen, K.; Ouyang, P. Cadaverine Production From L-Lysine with Chitin-Binding Protein-Mediated Lysine Decarboxylase Immobilization. Front. Bioeng. Biotechnol. 2020, 8, 103. [Google Scholar] [CrossRef]
  96. Vancamelbeke, M.; Vermeire, S. The intestinal barrier: A fundamental role in health and disease. Expert Rev. Gastroenterol. Hepatol. 2017, 11, 821–834. [Google Scholar] [CrossRef]
  97. Cantabrana, B.; Peña-Iglesias, P.; Castro-Estrada, P.; Suárez, L.; Bordallo, J.; Barreiro-Alonso, E.; Sánchez, M. Dietary intake of polyamines in a Spanish adult population: Age-dependent correlation with Healthy Eating Index and Dietary Inflammatory Index scores. Nutrition 2025, 130, 112608. [Google Scholar] [CrossRef] [PubMed]
  98. Hirano, R.; Shirasawa, H.; Kurihara, S. Health-Promoting Effects of Dietary Polyamines. Med. Sci. 2021, 9, 8. [Google Scholar] [CrossRef] [PubMed]
  99. Rezac, S.; Kok, C.R.; Heermann, M.; Hutkins, R. Fermented Foods as a Dietary Source of Live Organisms. Front. Microbiol. 2018, 9, 1785. [Google Scholar] [CrossRef] [PubMed]
  100. Sampsell, K.; Marcolla, C.S.; Tapping, S.; Fan, Y.; Sánchez-Lafuente, C.L.; Willing, B.P.; Reimer, R.A.; Burton, J.P. Current Research in Fermented Foods: Bridging Tradition and Science. Adv. Nutr. 2025, 16, 100554. [Google Scholar] [CrossRef]
  101. Atiya Ali, M.; Poortvliet, E.; Strömberg, R.; Yngve, A. Polyamines in foods: Development of a food database. Food Nutr. Res. 2011, 55, 5572. [Google Scholar] [CrossRef]
  102. Dankar, I.; Melhem, A.; Serhan, M.; Hassan, H.F. Microbial and processing factors affecting biogenic amine formation and accumulation in dairy: A narrative review. Appl. Food Res. 2025, 5, 101376. [Google Scholar] [CrossRef]
  103. Aladhadh, M.; Nasser Binjawhar, D.; Abd El-Kader Ebrahim, H.N.E.-D.; Radhi, K.S.; Almatrafi, M.; Fayad, E.; Al-Saman, M.A.; Elsanhoty, R.M. Investigation of Biogenic Amine Levels and Microbiological Activity as Quality Markers in Some Dairy and Fish Products in Food Markets in the Kingdom of Saudi Arabia. ACS Omega 2024, 9, 19193–19202. [Google Scholar] [CrossRef]
  104. Anwar, A.; Faiz, M.A.; Badar, I.H.; Jaspal, M.H.; Hou, J. Influence of Fermentation Time and Storage Conditions on the Physicochemical Properties of Different Yogurt Varieties Using Starter Cultures and Probiotic Lactobacillus rhamnosus GG. Processes 2025, 13, 759. [Google Scholar] [CrossRef]
  105. Tan, X.; Cui, F.; Wang, D.; Lv, X.; Li, X.; Li, J. Fermented Vegetables: Health Benefits, Defects, and Current Technological Solutions. Foods 2023, 13, 38. [Google Scholar] [CrossRef]
  106. Bernacka, K.; Sozański, T.; Kucharska, A.Z. Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications. Nutrients 2025, 17, 1989. [Google Scholar] [CrossRef]
  107. Craig, W.J.; Mangels, A.R.; Fresán, U.; Marsh, K.; Miles, F.L.; Saunders, A.V.; Haddad, E.H.; Heskey, C.E.; Johnston, P.; Larson-Meyer, E.; et al. The Safe and Effective Use of Plant-Based Diets with Guidelines for Health Professionals. Nutrients 2021, 13, 4144. [Google Scholar] [CrossRef] [PubMed]
  108. Jia, J.; Dell’Olio, A.; Izquierdo-Sandoval, D.; Capuano, E.; Liu, X.; Duan, X.; Rubert, J. Exploiting the interactions between plant proteins and gut microbiota to promote intestinal health. Trends Food Sci. Technol. 2024, 153, 104749. [Google Scholar] [CrossRef]
  109. Meitha, K.; Pramesti, Y.; Suhandono, S. Reactive Oxygen Species and Antioxidants in Postharvest Vegetables and Fruits. Int. J. Food Sci. 2020, 2020, 1–11. [Google Scholar] [CrossRef]
  110. Das, A.K.; Nanda, P.K.; Dandapat, P.; Bandyopadhyay, S.; Gullón, P.; Sivaraman, G.K.; McClements, D.J.; Gullón, B.; Lorenzo, J.M. Edible Mushrooms as Functional Ingredients for Development of Healthier and More Sustainable Muscle Foods: A Flexitarian Approach. Molecules 2021, 26, 2463. [Google Scholar] [CrossRef]
  111. Mafe, A.N.; Otieno, C.A.; Edo, G.I.; Akpoghelie, P.O.; Yousif, E.; Isoje, E.F.; Igbuku, U.A.; Ismael, S.A.; Makia, R.S.; Essaghah, A.E.A.; et al. Domestication and market potential of indigenous mushrooms in Nigeria and Kenya through cultivation techniques, nutritional enhancement, and consumer preference analysis. Discov. Food 2025, 5, 248. [Google Scholar] [CrossRef]
  112. Kontominas, M.G.; Badeka, A.V.; Kosma, I.S.; Nathanailides, C.I. Recent Developments in Seafood Packaging Technologies. Foods 2021, 10, 940. [Google Scholar] [CrossRef]
  113. Toldrá, F.; Reig, M. The stability and shelf life of seafood. In Food and Beverage Stability and Shelf Life; Elsevier: Amsterdam, The Netherlands, 2011; pp. 779–792. [Google Scholar]
  114. Schirone, M.; Esposito, L.; D’Onofrio, F.; Visciano, P.; Martuscelli, M.; Mastrocola, D.; Paparella, A. Biogenic Amines in Meat and Meat Products: A Review of the Science and Future Perspectives. Foods 2022, 11, 788. [Google Scholar] [CrossRef]
  115. Drabik-Markiewicz, G.; Dejaegher, B.; De Mey, E.; Kowalska, T.; Paelinck, H.; Vander Heyden, Y. Influence of putrescine, cadaverine, spermidine or spermine on the formation of N-nitrosamine in heated cured pork meat. Food Chem. 2011, 126, 1539–1545. [Google Scholar] [CrossRef]
  116. Salek, R.N.; Pleva, P.; Sumczynski, D.; Vinter, Š.; Kopečková, J.; Rejdlová, A.; Lorencová, E. Sauerkraut juice fermented with different symbiotic starter cultures: Comprehensive assessment of physicochemical, rheological, antioxidant, and microbiological characteristics. Front. Sustain. Food Syst. 2025, 9, 1570465. [Google Scholar] [CrossRef]
  117. Christensen, L.F.; García-Béjar, B.; Bang-Berthelsen, C.H.; Hansen, E.B. Extracellular microbial proteases with specificity for plant proteins in food fermentation. Int. J. Food Microbiol. 2022, 381, 109889. [Google Scholar] [CrossRef]
  118. Siddiqui, S.A.; Erol, Z.; Rugji, J.; Taşçı, F.; Kahraman, H.A.; Toppi, V.; Musa, L.; Di Giacinto, G.; Bahmid, N.A.; Mehdizadeh, M.; et al. An overview of fermentation in the food industry—Looking back from a new perspective. Bioresour. Bioprocess. 2023, 10, 85. [Google Scholar] [CrossRef]
  119. Hofer, S.J.; Daskalaki, I.; Bergmann, M.; Friščić, J.; Zimmermann, A.; Mueller, M.I.; Abdellatif, M.; Nicastro, R.; Masser, S.; Durand, S.; et al. Spermidine is essential for fasting-mediated autophagy and longevity. Nat. Cell Biol. 2024, 26, 1571–1584. [Google Scholar] [CrossRef]
  120. Soda, K. Overview of Polyamines as Nutrients for Human Healthy Long Life and Effect of Increased Polyamine Intake on DNA Methylation. Cells 2022, 11, 164. [Google Scholar] [CrossRef] [PubMed]
  121. Shen, X.; Gao, X.; Wang, L. Intestinal aging-related immune dysfunction: Mechanisms and interventions. Acta Biochim. Biophys. Sin. 2026, 58, 183–200. [Google Scholar] [CrossRef] [PubMed]
  122. Garzon-Escamilla, N.; Medina-Cardena, M.; Roy, P.; Trent, J.; Jamous, J.; Somesan, Y.; Denslow, S.J. Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics. Biomedicines 2026, 14, 316. [Google Scholar] [CrossRef]
  123. Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.B.; Rahu, N. Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell. Longev. 2016, 2016, 7432797. [Google Scholar] [CrossRef]
  124. Vona, R.; Pallotta, L.; Cappelletti, M.; Severi, C.; Matarrese, P. The Impact of Oxidative Stress in Human Pathology: Focus on Gastrointestinal Disorders. Antioxidants 2021, 10, 201. [Google Scholar] [CrossRef] [PubMed]
  125. Kalogerakou, T.; Antoniadou, M. The Role of Dietary Antioxidants, Food Supplements and Functional Foods for Energy Enhancement in Healthcare Professionals. Antioxidants 2024, 13, 1508. [Google Scholar] [CrossRef] [PubMed]
  126. Soda, K.; Uemura, T.; Sanayama, H.; Igarashi, K.; Fukui, T. Polyamine-Rich Diet Elevates Blood Spermine Levels and Inhibits Pro-Inflammatory Status: An Interventional Study. Med. Sci. 2021, 9, 22. [Google Scholar] [CrossRef]
  127. Blachier, F.; Kong, X. Recycling of Undigested Proteins Provided by the Host to the Large Intestine Microbiota: Implication for Intestinal Bacterial Anabolism, Growth, and Physiology. Microorganisms 2025, 13, 2690. [Google Scholar] [CrossRef]
  128. Hinssen, F.; Mensink, M.; Huppertz, T.; van der Wielen, N. Impact of aging on the digestive system related to protein digestion in vivo. Crit. Rev. Food Sci. Nutr. 2025, 65, 5829–5845. [Google Scholar] [CrossRef]
  129. Świder, O.; Roszko, M.Ł.; Wójcicki, M. The inhibitory effects of plant additives on biogenic amine formation in fermented foods—A review. Crit. Rev. Food Sci. Nutr. 2024, 64, 12935–12960. [Google Scholar] [CrossRef]
  130. Rossi, M.N.; Cervelli, M. Polyamine Metabolism and Functions: Key Roles in Cellular Health and Disease. Biomolecules 2024, 14, 1570. [Google Scholar] [CrossRef] [PubMed]
  131. Novita Sari, I.; Setiawan, T.; Seock Kim, K.; Toni Wijaya, Y.; Won Cho, K.; Young Kwon, H. Metabolism and function of polyamines in cancer progression. Cancer Lett. 2021, 519, 91–104. [Google Scholar] [CrossRef]
  132. Li, J.; Meng, Y.; Wu, X.; Sun, Y. Polyamines and related signaling pathways in cancer. Cancer Cell Int. 2020, 20, 539. [Google Scholar] [CrossRef]
  133. Zhang, J.; Cai, C.; Zhang, Y.; Luo, C.; Huo, S.; Wang, K.; Shi, C.; Liu, J.; Xu, G. The functional roles and mechanisms of polyamines in age-related bone diseases. Cell. Mol. Life Sci. 2025, 83, 38. [Google Scholar] [CrossRef] [PubMed]
  134. Gieryńska, M.; Szulc-Dąbrowska, L.; Struzik, J.; Mielcarska, M.B.; Gregorczyk-Zboroch, K.P. Integrity of the Intestinal Barrier: The Involvement of Epithelial Cells and Microbiota—A Mutual Relationship. Animals 2022, 12, 145. [Google Scholar] [CrossRef]
  135. Klionsky, D.J.; Petroni, G.; Amaravadi, R.K.; Baehrecke, E.H.; Ballabio, A.; Boya, P.; Bravo-San Pedro, J.M.; Cadwell, K.; Cecconi, F.; Choi, A.M.K.; et al. Autophagy in major human diseases. EMBO J. 2021, 40, e108863. [Google Scholar] [CrossRef]
  136. Galasso, L.; Cappella, A.; Mulè, A.; Castelli, L.; Ciorciari, A.; Stacchiotti, A.; Montaruli, A. Polyamines and Physical Activity in Musculoskeletal Diseases: A Potential Therapeutic Challenge. Int. J. Mol. Sci. 2023, 24, 9798. [Google Scholar] [CrossRef]
  137. Madeo, F.; Bauer, M.A.; Carmona-Gutierrez, D.; Kroemer, G. Spermidine: A physiological autophagy inducer acting as an anti-aging vitamin in humans? Autophagy 2019, 15, 165–168. [Google Scholar] [CrossRef] [PubMed]
  138. Ghiselli, F.; Rossi, B.; Piva, A.; Grilli, E. Assessing Intestinal Health. In Vitro and Ex vivo Gut Barrier Models of Farm Animals: Benefits and Limitations. Front. Vet. Sci. 2021, 8, 723387. [Google Scholar] [CrossRef] [PubMed]
  139. Slifer, Z.M.; Blikslager, A.T. The Integral Role of Tight Junction Proteins in the Repair of Injured Intestinal Epithelium. Int. J. Mol. Sci. 2020, 21, 972. [Google Scholar] [CrossRef]
  140. Tervonen, A.; Ihalainen, T.O.; Nymark, S.; Hyttinen, J. Structural dynamics of tight junctions modulate the properties of the epithelial barrier. PLoS ONE 2019, 14, e0214876. [Google Scholar] [CrossRef]
  141. Armstrong, J.S. Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease. Br. J. Pharmacol. 2007, 151, 1154–1165. [Google Scholar] [CrossRef]
  142. Szabo, L.; Lejri, I.; Grimm, A.; Eckert, A. Spermidine Enhances Mitochondrial Bioenergetics in Young and Aged Human-Induced Pluripotent Stem Cell-Derived Neurons. Antioxidants 2024, 13, 1482. [Google Scholar] [CrossRef]
  143. Xu, X.; Pang, Y.; Fan, X. Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances. Signal Transduct. Target. Ther. 2025, 10, 190. [Google Scholar] [CrossRef]
  144. Carriche, G.M.; Almeida, L.; Stüve, P.; Velasquez, L.; Dhillon-LaBrooy, A.; Roy, U.; Lindenberg, M.; Strowig, T.; Plaza-Sirvent, C.; Schmitz, I.; et al. Regulating T-cell differentiation through the polyamine spermidine. J. Allergy Clin. Immunol. 2021, 147, 335–348.e11. [Google Scholar] [CrossRef]
  145. Akinyele, O.; Wallace, H.M. Understanding the Polyamine and mTOR Pathway Interaction in Breast Cancer Cell Growth. Med. Sci. 2022, 10, 51. [Google Scholar] [CrossRef]
  146. Wang, S.-Y.; Lee, Y.-L.; Lai, Y.-H.; Chen, J.J.W.; Wu, W.-L.; Yuann, J.-M.P.; Su, W.-L.; Chuang, S.-M.; Hou, M.-H. Spermine Attenuates the Action of the DNA Intercalator, Actinomycin D, on DNA Binding and the Inhibition of Transcription and DNA Replication. PLoS ONE 2012, 7, e47101. [Google Scholar] [CrossRef] [PubMed][Green Version]
  147. Iacomino, G.; Picariello, G.; D’Agostino, L. DNA and nuclear aggregates of polyamines. Biochim. Biophys. Acta-Mol. Cell Res. 2012, 1823, 1745–1755. [Google Scholar] [CrossRef]
  148. Vasilogiannakopoulou, T.; Begou, O.; Karali, C.S.; Efthymiou, G.; Roubelakis, M.; Gorgoulis, V.; Gkouskou, K.K.; Gika, H.; Eliopoulos, A.G. Putrescine functions as a metabolic checkpoint in replication stress-induced senescence. Cell. Mol. Life Sci. 2025, 82, 410. [Google Scholar] [CrossRef]
  149. Satarker, S.; Wilson, J.; Kolathur, K.K.; Mudgal, J.; Lewis, S.A.; Arora, D.; Nampoothiri, M. Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders. Eur. J. Pharmacol. 2024, 979, 176823. [Google Scholar] [CrossRef] [PubMed]
  150. Shu, F.; Xiao, H.; Li, Q.-N.; Ren, X.-S.; Liu, Z.-G.; Hu, B.-W.; Wang, H.-S.; Wang, H.; Jiang, G.-M. Epigenetic and post-translational modifications in autophagy: Biological functions and therapeutic targets. Signal Transduct. Target. Ther. 2023, 8, 32. [Google Scholar] [CrossRef]
  151. Li, S.; Wang, C.; Zhang, L.; Chen, S.; Zhou, Y.; Yang, D.; Li, K.; Liu, Y.; Chi, S.; Wang, Y.; et al. Tight junction dysfunction and cytoskeletal remodeling in Hirschsprung-associated enterocolitis: A decade of mechanistic insights and therapeutic prospects (Review). Mol. Med. Rep. 2025, 33, 28. [Google Scholar] [CrossRef] [PubMed]
  152. Penrose, H.M.; Marchelletta, R.R.; Krishnan, M.; McCole, D.F. Spermidine Stimulates T Cell Protein-tyrosine Phosphatase-mediated Protection of Intestinal Epithelial Barrier Function. J. Biol. Chem. 2013, 288, 32651–32662. [Google Scholar] [CrossRef][Green Version]
  153. Song, N.; Ji, E.; Yu, J.E.; Choi, K.-H.; Kim, D.-H.; Song, J.-M.; Kang, D.-H.; Song, J.-K.; Yu, J.; Kim, K.; et al. Spermidine Enhances Mitochondrial Function and Mitigates Aortic Valve Calcification. JACC Basic to Transl. Sci. 2025, 10, 345–366. [Google Scholar] [CrossRef]
  154. Wang, L.; Li, W.; Liu, Y.; Dilixiati, A.; Chang, Z.; Liang, Y.; Wang, Y.; Ma, X.; Tang, L.; He, Z.; et al. Spermidine Supplementation Effectively Improves the Quality of Mouse Oocytes After Vitrification Freezing. Antioxidants 2025, 14, 224. [Google Scholar] [CrossRef]
  155. Fagiani, F.; Catanzaro, M.; Buoso, E.; Basagni, F.; Di Marino, D.; Raniolo, S.; Amadio, M.; Frost, E.H.; Corsini, E.; Racchi, M.; et al. Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds. Front. Pharmacol. 2020, 11, 1256. [Google Scholar] [CrossRef] [PubMed]
  156. Zlatanova, M.; Nešić, A.; Trbojević-Ivić, J.; Četić, D.; Gavrović-Jankulović, M. Targeting NF-κB Signaling: Selected Small Molecules Downregulate Pro-Inflammatory Cytokines in Both Food Allergen and LPS-Induced Inflammation. Int. J. Mol. Sci. 2024, 25, 5798. [Google Scholar] [CrossRef]
  157. Liu, S.; Liu, Y.; Zhao, J.; Yang, P.; Wang, W.; Liao, M. Effects of Spermidine on Gut Microbiota Modulation in Experimental Abdominal Aortic Aneurysm Mice. Nutrients 2022, 14, 3349. [Google Scholar] [CrossRef] [PubMed]
  158. Compare, D.; Sgamato, C.; Rocco, A.; Coccoli, P.; Ambrosio, C.; Nardone, G. The Leaky Gut and Human Diseases: “Can’t Fill the Cup if You Don’t Plug the Holes First”. Dig. Dis. 2024, 42, 548–566. [Google Scholar] [CrossRef]
  159. Ignatiou, A.; Pitsouli, C. Host–diet–microbiota interplay in intestinal nutrition and health. FEBS Lett. 2024, 598, 2482–2517. [Google Scholar] [CrossRef]
  160. Hernández-Acosta, J.; Tovar, A.; Torres, N. Sex-Specific Diet–Microbiota Interactions in Ageing: Implications for Healthy Longevity. Nutrients 2025, 17, 3833. [Google Scholar] [CrossRef] [PubMed]
  161. Sheflin, A.M.; Melby, C.L.; Carbonero, F.; Weir, T.L. Linking dietary patterns with gut microbial composition and function. Gut Microbes 2017, 8, 113–129. [Google Scholar] [CrossRef]
  162. Singh, R.K.; Chang, H.-W.; Yan, D.; Lee, K.M.; Ucmak, D.; Wong, K.; Abrouk, M.; Farahnik, B.; Nakamura, M.; Zhu, T.H.; et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017, 15, 73. [Google Scholar] [CrossRef]
  163. Shah, P.; Swiatlo, E. A multifaceted role for polyamines in bacterial pathogens. Mol. Microbiol. 2008, 68, 4–16. [Google Scholar] [CrossRef] [PubMed]
  164. Santa, D.; Huch, M.; Stoll, D.A.; Cunedioglu, H.; Priidik, R.; Karakaş-Budak, B.; Matalas, A.; Pennone, V.; Girija, A.; Arranz, E.; et al. Health benefits of ethnic fermented foods. Front. Nutr. 2025, 12, 1677478. [Google Scholar] [CrossRef]
  165. Baron, K.; Stasolla, C. The role of polyamines during in vivo and in vitro development. Vitr. Cell. Dev. Biol.-Plant 2008, 44, 384–395. [Google Scholar] [CrossRef]
  166. del Rio, B.; Fernandez, M.; Redruello, B.; Ladero, V.; Alvarez, M.A. New insights into the toxicological effects of dietary biogenic amines. Food Chem. 2024, 435, 137558. [Google Scholar] [CrossRef]
  167. Ruiz-Capillas, C.; Herrero, A. Impact of Biogenic Amines on Food Quality and Safety. Foods 2019, 8, 62. [Google Scholar] [CrossRef] [PubMed]
  168. Vermelho, A.B.; Cardoso, V.d.S.; Domingos, L.T.S.; Akamine, I.T.; Amenu, B.; Osei, B.K.; Neves Junior, A. Advancements in Microbial Applications for Sustainable Food Production. Foods 2025, 14, 3427. [Google Scholar] [CrossRef]
  169. Tsafack, P.B.; Tsopmo, A. Effects of bioactive molecules on the concentration of biogenic amines in foods and biological systems. Heliyon 2022, 8, e10456. [Google Scholar] [CrossRef]
  170. Lu, B.; Wang, L.; Ran, X.; Tang, H.; Cao, D. Recent Advances in Fluorescent Methods for Polyamine Detection and the Polyamine Suppressing Strategy in Tumor Treatment. Biosensors 2022, 12, 633. [Google Scholar] [CrossRef]
  171. Minetti, A.; Omrani, O.; Brenner, C.; Cansiz, F.; Imada, S.; Rösler, J.; Khawaled, S.; Allies, G.; Meckelmann, S.W.; Gebert, N.; et al. Polyamines sustain epithelial regeneration in aged intestines by modulating protein homeostasis. Nat. Cell Biol. 2025, 27, 2063–2077. [Google Scholar] [CrossRef]
  172. Spano, G.; Russo, P.; Lonvaud-Funel, A.; Lucas, P.; Alexandre, H.; Grandvalet, C.; Coton, E.; Coton, M.; Barnavon, L.; Bach, B.; et al. Biogenic amines in fermented foods. Eur. J. Clin. Nutr. 2010, 64, S95–S100. [Google Scholar] [CrossRef]
  173. Gangakhedkar, P.S.; Deshpande, H.W.; Törős, G.; El-Ramady, H.; Elsakhawy, T.; Abdalla, N.; Shaikh, A.; Kovács, B.; Mane, R.; Prokisch, J. Fermentation of Fruits and Vegetables: Bridging Traditional Wisdom and Modern Science for Food Preservation and Nutritional Value Improvements. Foods 2025, 14, 2155. [Google Scholar] [CrossRef]
  174. Xu, Y.; Song, J.; Huang, Q.; Wei, X.; Deng, Z.; Song, Z.; Huang, H.; Luo, C.; Zhang, D.; Han, L. Functional foods and nutraceuticals with anti-aging effects: Focus on modifying the enteral microbiome. J. Funct. Foods 2025, 128, 106786. [Google Scholar] [CrossRef]
  175. Ni, Y.-Q.; Liu, Y.-S. New Insights into the Roles and Mechanisms of Spermidine in Aging and Age-Related Diseases. Aging Dis. 2021, 12, 1948. [Google Scholar] [CrossRef] [PubMed]
  176. Zamfir, L.-G.; Răut, I.; Constantin, M.; Olguța Corneli, N.; Firincă, C.; Jecu, M.-L.; Epure, P.; Nistor, C.L.; Doni, M.; Gurban, A.-M. Assessment of biogenic amines produced by microorganisms as food spoilage indicators by sensitive detection using portable opto-electrochemical tools based on biosensors. Food Control 2025, 172, 111161. [Google Scholar] [CrossRef]
  177. del Rio, B.; Redruello, B.; Linares, D.M.; Ladero, V.; Ruas-Madiedo, P.; Fernandez, M.; Martin, M.C.; Alvarez, M.A. The biogenic amines putrescine and cadaverine show in vitro cytotoxicity at concentrations that can be found in foods. Sci. Rep. 2019, 9, 120. [Google Scholar] [CrossRef] [PubMed]
  178. Saha Turna, N.; Chung, R.; McIntyre, L. A review of biogenic amines in fermented foods: Occurrence and health effects. Heliyon 2024, 10, e24501. [Google Scholar] [CrossRef]
  179. Biji, K.B.; Ravishankar, C.N.; Venkateswarlu, R.; Mohan, C.O.; Gopal, T.K.S. Biogenic amines in seafood: A review. J. Food Sci. Technol. 2016, 53, 2210–2218. [Google Scholar] [CrossRef]
  180. Tabanelli, G. Biogenic Amines and Food Quality: Emerging Challenges and Public Health Concerns. Foods 2020, 9, 859. [Google Scholar] [CrossRef]
  181. Ding, T.; Li, Y. Biogenic amines are important indices for characterizing the freshness and hygienic quality of aquatic products: A review. LWT 2024, 194, 115793. [Google Scholar] [CrossRef]
Figure 1. Pathways of Microbial and Host Polyamine Biosynthesis (created with BioRender, https://app.biorender.com/illustrations/695269d08651c8e950a2fb6b accessed on 9 January 2026).
Figure 1. Pathways of Microbial and Host Polyamine Biosynthesis (created with BioRender, https://app.biorender.com/illustrations/695269d08651c8e950a2fb6b accessed on 9 January 2026).
Nutrients 18 00578 g001
Figure 2. “Young” vs. “Aged” Intestine: Sites of Polyamine Action (created with BioRender). https://app.biorender.com/illustrations/695275e5717757622b97a4f9 accessed on 9 January 2026.
Figure 2. “Young” vs. “Aged” Intestine: Sites of Polyamine Action (created with BioRender). https://app.biorender.com/illustrations/695275e5717757622b97a4f9 accessed on 9 January 2026.
Nutrients 18 00578 g002
Figure 3. Biophysical mechanisms of polyamine action at cellular and molecular levels (created with BioRender https://app.biorender.com/illustrations/695275f96834159ac0a654dc accessed on 7 January 2026).
Figure 3. Biophysical mechanisms of polyamine action at cellular and molecular levels (created with BioRender https://app.biorender.com/illustrations/695275f96834159ac0a654dc accessed on 7 January 2026).
Nutrients 18 00578 g003
Figure 4. Diet–Microbiota–Polyamine Axis (created with BioRender https://app.biorender.com/illustrations/69527fcd132544d6ca0ec95e accessed on 9 January 2026).
Figure 4. Diet–Microbiota–Polyamine Axis (created with BioRender https://app.biorender.com/illustrations/69527fcd132544d6ca0ec95e accessed on 9 January 2026).
Nutrients 18 00578 g004
Table 1. Microbial Species Involved in Polyamine Biosynthesis.
Table 1. Microbial Species Involved in Polyamine Biosynthesis.
Microbial GroupRepresentative SpeciesMajor Polyamines ProducedBiosynthetic PathwayRelevance to Aging GutStrain-Dependent VariabilityEvidence TypeReference
Lactic acid bacteria (LAB)Lactobacillus plantarum, L. caseiPutrescine, spermidineArginine/ornithine decarboxylationWidely used probiotics; safe and diet-accessibleHigh—production capacity varies markedly between strainsIn vitro; fermented food models[40,41]
BifidobacteriaB. longum, B. adolescentisSpermidine, spermineAmino acid metabolism & cross-feedingDeclines with age; key target for interventionModerate—influenced by strain genetics and substrate availabilityIn vitro; animal/in vivo[42]
EnterococciEnterococcus faeciumPutrescineOrnithine decarboxylaseDual role: beneficial or opportunisticHigh—some strains are associated with excessive amine productionIn vitro[43,44]
Bacillus sp.B. subtilisSpermidinePolyamine synthase pathwaysRelevant in fermented foodsModerate—dependent on fermentation conditions and strain selectionIn vitro; food fermentation studies[45,46]
StreptococciStreptococcus thermophilusPutrescineArginine metabolismCommon dairy starter cultureLow–moderate—strain differences reportedIn vitro; dairy fermentation models[47,48]
PathobiontsProteus sp., Clostridium sp.Putrescine, cadaverineUnregulated decarboxylationLinked to dysbiosis and toxicityHigh—strain-specific overproduction under dysbiotic conditionsIn vitro; animal/in vivo[49,50]
Note: Polyamine production capacity varies substantially at the strain level and cannot be generalized at the species level; environmental conditions and substrate availability further modulate biosynthetic output.
Table 2. Polyamine Content in Common Foods.
Table 2. Polyamine Content in Common Foods.
Food CategoryRepresentative FoodsDominant PolyaminesRelative ContentNotes Relevant to AgingReference
Fermented dairyYogurt, cheeseSpermidine, putrescineHighContent depends on starter cultures and ripening[104]
Fermented vegetablesSauerkraut, kimchiPutrescine, spermidineHighCan be optimized through controlled fermentation[105,106]
Legumes & whole grainsSoybeans, lentils, wheat germSpermidineModerate–HighMajor contributors in plant-based diets[107,108]
Fruits & vegetablesCitrus fruits, tomatoes, spinachPutrescineLow–ModerateContent varies with maturity[109]
MushroomsButton, shiitakeSpermidine, spermineModerateEmerging functional food interest[110,111]
SeafoodFish, shellfishSpermine, putrescineVariableSensitive to storage and spoilage[112,113]
Processed meatsSausages, cured meatsPutrescine, cadaverineHigh (undesirable)Associated with spoilage and safety concerns[114,115]
Note: Polyamine content in fermented foods is highly dependent on starter culture composition, strain selection, fermentation conditions, and storage duration.
Table 3. Effects of Polyamines on Intestinal Aging Biomarkers.
Table 3. Effects of Polyamines on Intestinal Aging Biomarkers.
Aging-Related BiomarkerEffect of PolyaminesDominant PolyamineMechanistic BasisReferences
DNA integrityProtection and stabilizationSpermidine, spermineElectrostatic binding to nucleic acids[146,147]
Epithelial turnoverIncreased proliferationPutrescineCell cycle regulation[148]
Autophagic fluxUpregulationSpermidinemTOR inhibition, epigenetic modulation[149,150]
Tight junction integrityPreservationSpermidineCytoskeletal and protein assembly support[151,152]
Mitochondrial functionEnhanced efficiencySpermidineReduced ROS, membrane stabilization[153,154]
Inflammatory toneSuppressionSpermidine, spermineNF-κB and cytokine modulation[155,156]
Intestinal permeabilityReduced (“leaky gut”)SpermidineBarrier reinforcement[157,158]
Table 4. Beneficial versus Toxic Polyamines in Food Systems.
Table 4. Beneficial versus Toxic Polyamines in Food Systems.
Polyamine/AminePrimary SourcePhysiological RoleRisk at High LevelsFood Safety RelevanceReferences
SpermidineDiet, microbiotaLongevity, autophagyLow toxicityTarget compound for functional foods[119,174]
SpermineDiet, host cellsDNA stabilizationMinimal riskNaturally regulated[175]
PutrescineMicrobes, foodsCell proliferationGI irritationIndicator of spoilage[176,177]
CadaverineSpoilage bacteriaNone (toxic by-product)Histamine potentiationMajor food safety concern[178,179]
HistamineSpoiled fish, fermented foodsNeuroactiveHypertension, headachesRegulated biogenic amine[180,181]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mafe, A.N.; Büsselberg, D. The Diet–Microbiota–Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications. Nutrients 2026, 18, 578. https://doi.org/10.3390/nu18040578

AMA Style

Mafe AN, Büsselberg D. The Diet–Microbiota–Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications. Nutrients. 2026; 18(4):578. https://doi.org/10.3390/nu18040578

Chicago/Turabian Style

Mafe, Alice N., and Dietrich Büsselberg. 2026. "The Diet–Microbiota–Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications" Nutrients 18, no. 4: 578. https://doi.org/10.3390/nu18040578

APA Style

Mafe, A. N., & Büsselberg, D. (2026). The Diet–Microbiota–Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications. Nutrients, 18(4), 578. https://doi.org/10.3390/nu18040578

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop